CI 994

Discontinued Product

CI 994 (Cat. No. 2952) has been withdrawn from sale for commercial reasons.
Description: Class I histone deacetylase inhibitor; orally active
Alternative Names: N-acetyldinaline
Chemical Name: 4-(Acetylamino)-N-(2-aminophenyl)benzamide
Purity: ≥99% (HPLC)
Literature (4)

Biological Activity for CI 994

CI 994 is an orally active class I histone deacetylase (HDAC) inhibitor (Ki values are 0.41, 0.75, >100 and >100 μM for HDAC1, HDAC3, HDAC6 and HDAC8 respectively). Mediates G1 cell cycle arrest, inhibits proliferation and induces apoptosis in vitro and in vivo. Increases neuroplasticity during memory extinction. Also increases efficiency of hepatic differentiation of hPSCs

Compound Libraries for CI 994

CI 994 is also offered as part of the Tocriscreen 2.0 Max, Tocriscreen Antiviral Library, Tocriscreen Epigenetics Library and Tocriscreen Stem Cell Library. Find out more about compound libraries available from Tocris.

Technical Data for CI 994

M. Wt 269.3
Formula C15H15N3O2
Storage Store at +4°C
Purity ≥99% (HPLC)
CAS Number 112522-64-2
PubChem ID 2746
Smiles O=C(NC2=C(N)C=CC=C2)C1=CC=C(NC(C)=O)C=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for CI 994

References are publications that support the biological activity of the product.

Beckers et al (2007) Distinct pharamacologcial properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int.J.Cancer 121 1138 PMID: 17455259

Gräff et al (2014) Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell 156 261 PMID: 24439381

Kraker et al (2003) Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benamide] in HCT-8 colon carcinoma. Mol.Cancer Ther. 2 401 PMID: 12700284

View Related Products by Product Action

View all Class I HDAC Inhibitors

Keywords: CI 994, CI 994 supplier, Histone, deacetylases, inhibitors, inhibits, HDAC, Class, I, CI994, epigenetics, HDAC1, HDAC2, HDAC3, HDAC8, hepatocyte, differentiation, N-acetyldinaline, HDACs, Hepatocyte, Stem, Cells, 2952, Tocris Bioscience

Citations for CI 994

Citations are publications that use Tocris products.

Currently there are no citations for CI 994.

Reviews for CI 994

There are currently no reviews for this product. Be the first to review CI 994 and earn rewards!

Have you used CI 994?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Epigenetics Scientific Review

Epigenetics Scientific Review

Written by Susanne Müller-Knapp and Peter J. Brown, this review gives an overview of the development of chemical probes for epigenetic targets, as well as the impact of these tool compounds being made available to the scientific community. In addition, their biological effects are also discussed. Epigenetic compounds available from Tocris are listed.

Cell Cycle & DNA Damage Repair Poster

Cell Cycle & DNA Damage Repair Poster

In normal cells, each stage of the cell cycle is tightly regulated, however in cancer cells many genes and proteins that are involved in the regulation of the cell cycle are mutated or over expressed. This poster summarizes the stages of the cell cycle and DNA repair. It also highlights strategies for enhancing replicative stress in cancer cells to force mitotic catastrophe and cell death.

Epigenetics in Cancer Poster

Epigenetics in Cancer Poster

This poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.

Rheumatoid Arthritis Poster

Rheumatoid Arthritis Poster

Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.